Core offer
Untold Stories, Life with a Severe Autoimmune Condition
Argenics: Untold Stories, Life with a Severe Autoimmune Condition · Jul 8–17, 2026
ActiveArgenics partners with Ruby Studio to produce "Untold Stories, Life with a Severe Autoimmune Condition," a podcast that explores the experiences of individuals living with various rare autoimmune conditions and fosters a sense of community.
Jul 8, 2026
First seen
Jul 17, 2026
Last seen
5
Reads
1
Shows
1
Active months
36s
Avg. length
13-week activity
Public campaign reads by observed week
3
1
1
Renewal signals
30 dayNo
60 dayPending
90 dayPending
Promo-code persistence
No recurring promo code was observed.
Shows
Where the campaign appeared
Placements
pre-roll5
Categories
Representative reads
Examples across the campaignExample transcript
The read that best represents this campaign's recurring script
The Bobby Bones Show·WEDS PT 1: Bobby Has Crazy Breaking NEWS! + Amy Got Scolded By A Dad At The Airport…Then Karma Hit + Lunchbox Is Mad Abby Got ‘Miranda Lambert’ Gig
Est. value ~$860range $160–$5.9K
Living with a rare autoimmune condition brings uncertainty, but it can also create community. In Season 6 of Untold Stories, Life with a Severe Autoimmune Condition, they go beyond MG and CIDP as host Martine Hackett welcomes stories from other conditions like myositis and Igan into the conversation. Untold Stories is produced by Ruby Studio in partnership with Argenics. Listen to Untold Stories, life with a severe autoimmune condition on the iHeartRadio app, Apple Podcasts, or wherever you get your podcasts.
More campaigns from Argenics
Other published campaigns from this sponsor
Argenics: Vivgard Hytrulo Pre-Filled Syringe for self-injection · Jul 10–Aug 10, 2026Expanding
The campaign promotes the Vivgard Hytrulo Pre-Filled Syringe for self-injection, emphasizing the convenience of administering treatment on one's own time and in one's own space.
5 reads5 showsLast seen Aug 10
Argenics: Vivgard Hytrulo, Efgard Tigamod Alpha, and Hyaluronidase QVFC pre-filled… · Jul 29–Aug 8, 2026New
Argenics advertised the Vivgard Hytrulo, Efgard Tigamod Alpha, and Hyaluronidase QVFC pre-filled syringe, emphasizing its convenience for self-injection as part of a flexible treatment routine.
4 reads3 showsLast seen Aug 8
These signals describe observed podcast advertising activity. Per-read dollar figures are directional current placement proxies—not historical campaign spend, reach, conversions, or return on investment.